The epidemiology of EBV and its association with malignant disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
EPSTEIN-BARR VIRUS EPIDEMIOLOGY Epidemiology of primary Epstein-Barr virus infection Epstein-Barr virus (EBV) is an ancient virus, and has probably coevolved with its different hosts over the last 90–100 million years (McGeoch et al ., 1995). With the ability to establish lifelong latency and intermittent reactivation after primary infection and with limited clinical symptoms in the majority of infected individuals, EBV has become ubiquitous in all human populations Age at primary infection Children in developing countries acquire the infection in the first few years of life, and universal seroconversion is often seen by ages 3–4 years, whereas infection in developed countries often is delayed until adolescence (de The et al ., 1975; Haahr et al ., 2004; Henle and Henle, 1967; Melbye et al ., 1984a,b) (Figure 53.1). In some developed countries a bimodal infection rate, with peaks in children below 5 years and again after 10 years of age, has been described (Edwards and Woodroof, 1979; Henle and Henle, 1967; Lai et al ., 1975). Oral EBV excretion between parents and infants, and from intimate partners in adolescence and early adulthood is the likely explanation for the observed bimodality (Crawford et al ., 2002; Fleisher et al ., 1979). EBV antibody titers in seropositive individuals vary according to age following a U-shaped pattern, with high titers among infants and in the elderly (above 50 years) (Glaser et al ., 1985; Venkitaraman et al ., 1985).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., & Miyoshi, I. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6476 · Cited by 2,252
Cited by
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
Lazear, H. M., & Diamond, M. S. (2016) · Journal of Virology · doi:10.1128/jvi.00252-16 · Cited by 455
Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis646 · Cited by 337
Smatti, M. K., Al-Sadeq, D. W., Ali, N. H., Pintus, G., Abou-Saleh, H., & Nasrallah, G. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00211 · Cited by 309
Balfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
Metadata
- Authors
- Hjalgrim, H., Friborg, J., & Melbye, M.
- Venue
- Human Herpesviruses
- Publisher
- Cambridge University Press
- Published
- 2007-08-16
- Pages
- 929-959
- OpenAlex
- W1531490664
- Cited by
- 148
- References
- 2
- FWCI
- 1.41
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiology of EBV and its association with malignant disease. https://app.cochat.ai/papers/10.1017/cbo9780511545313.054
- The paper
- Hjalgrim, H., Friborg, J., & Melbye, M. (2007). The epidemiology of EBV and its association with malignant disease. Human Herpesviruses. https://doi.org/10.1017/cbo9780511545313.054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.